Golomidova et al. demonstrated that fullerenols C60(OH)30 and C70(OH)30 exerted neuroprotective effects in a Drosophila melanogaster PD model, reducing alpha-synuclein aggregation and oxidative stress, normalizing dopamine levels, and dopaminergic neuron counts in the A53T mutants [41]. Here, SNCA is linked to Parkinson disease.